Literature DB >> 30179220

Short telomere syndromes cause a primary T cell immunodeficiency.

Christa L Wagner1, Vidya Sagar Hanumanthu1, C Conover Talbot2, Roshini S Abraham3, David Hamm4, Dustin L Gable1, Christopher G Kanakry1, Carolyn D Applegate5, Janet Siliciano6, J Brooks Jackson7, Stephen Desiderio2,8,9, Jonathan K Alder1, Leo Luznik1,8, Mary Armanios1,5,7,8,9.   

Abstract

The mechanisms that drive T cell aging are not understood. We report that children and adult telomerase mutation carriers with short telomere length (TL) develop a T cell immunodeficiency that can manifest in the absence of bone marrow failure and causes life-threatening opportunistic infections. Mutation carriers shared T cell-aging phenotypes seen in adults 5 decades older, including depleted naive T cells, increased apoptosis, and restricted T cell repertoire. T cell receptor excision circles (TRECs) were also undetectable or low, suggesting that newborn screening may identify individuals with germline telomere maintenance defects. Telomerase-null mice with short TL showed defects throughout T cell development, including increased apoptosis of stimulated thymocytes, their intrathymic precursors, in addition to depleted hematopoietic reserves. When we examined the transcriptional programs of T cells from telomerase mutation carriers, we found they diverged from older adults with normal TL. Short telomere T cells upregulated DNA damage and intrinsic apoptosis pathways, while older adult T cells upregulated extrinsic apoptosis pathways and programmed cell death 1 (PD-1) expression. T cells from mice with short TL also showed an active DNA-damage response, in contrast with old WT mice, despite their shared propensity to apoptosis. Our data suggest there are TL-dependent and TL-independent mechanisms that differentially contribute to distinct molecular programs of T cell apoptosis with aging.

Entities:  

Keywords:  Aging; Genetics; Telomeres

Mesh:

Substances:

Year:  2018        PMID: 30179220      PMCID: PMC6264634          DOI: 10.1172/JCI120216

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  52 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis.

Authors:  L Chin; S E Artandi; Q Shen; A Tam; S L Lee; G J Gottlieb; C W Greider; R A DePinho
Journal:  Cell       Date:  1999-05-14       Impact factor: 41.582

3.  Species-diversity and pattern-diversity in the study of ecological succession.

Authors:  E C Pielou
Journal:  J Theor Biol       Date:  1966-02       Impact factor: 2.691

4.  Telomere dysfunction impairs DNA repair and enhances sensitivity to ionizing radiation.

Authors:  K K Wong; S Chang; S R Weiler; S Ganesan; J Chaudhuri; C Zhu; S E Artandi; K L Rudolph; G J Gottlieb; L Chin; F W Alt; R A DePinho
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

Review 5.  CD57 in human natural killer cells and T-lymphocytes.

Authors:  Hassen Kared; Serena Martelli; Tze Pin Ng; Sylvia L F Pender; Anis Larbi
Journal:  Cancer Immunol Immunother       Date:  2016-02-05       Impact factor: 6.968

6.  Phosphorylation of H2AX at short telomeres in T cells and fibroblasts.

Authors:  Ling-Yang Hao; Margaret A Strong; Carol W Greider
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

Review 7.  Understanding immunosenescence to improve responses to vaccines.

Authors:  Jörg J Goronzy; Cornelia M Weyand
Journal:  Nat Immunol       Date:  2013-04-18       Impact factor: 25.606

8.  Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (DKC1) gene.

Authors:  Jonathan K Alder; Erin M Parry; Srinivasan Yegnasubramanian; Christa L Wagner; Lawrence M Lieblich; Robert Auerbach; Arleen D Auerbach; Sarah J Wheelan; Mary Armanios
Journal:  Hum Mutat       Date:  2013-09-11       Impact factor: 4.878

Review 9.  Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder.

Authors:  Galina Glousker; Fabien Touzot; Patrick Revy; Yehuda Tzfati; Sharon A Savage
Journal:  Br J Haematol       Date:  2015-05-04       Impact factor: 6.998

10.  Lung transplantation in telomerase mutation carriers with pulmonary fibrosis.

Authors:  Leann L Silhan; Pali D Shah; Daniel C Chambers; Laurie D Snyder; Gerdt C Riise; Christa L Wagner; Eva Hellström-Lindberg; Jonathan B Orens; Juliette F Mewton; Sonye K Danoff; Murat O Arcasoy; Mary Armanios
Journal:  Eur Respir J       Date:  2014-05-15       Impact factor: 16.671

View more
  42 in total

Review 1.  Cellular Senescence: The Trojan Horse in Chronic Lung Diseases.

Authors:  Shruthi Hamsanathan; Jonathan K Alder; Jacobo Sellares; Mauricio Rojas; Aditi U Gurkar; Ana L Mora
Journal:  Am J Respir Cell Mol Biol       Date:  2019-07       Impact factor: 6.914

2.  Synonymous Mutation in DKC1 Causes Telomerase RNA Insufficiency Manifesting as Familial Pulmonary Fibrosis.

Authors:  Valeriya Gaysinskaya; Susan E Stanley; Soheir Adam; Mary Armanios
Journal:  Chest       Date:  2020-07-22       Impact factor: 9.410

3.  Peripheral blood leukocyte telomere length is associated with survival of sepsis patients.

Authors:  Shuo Liu; Chunxue Wang; Gary Green; Hanjing Zhuo; Kathleen D Liu; Kirsten N Kangelaris; Antonio Gomez; Alejandra Jauregui; Kathryn Vessel; Serena Ke; Carolyn Hendrickson; Michael A Matthay; Carolyn S Calfee; Lorraine B Ware; Paul J Wolters
Journal:  Eur Respir J       Date:  2020-01-16       Impact factor: 16.671

Review 4.  Expression and regulation of telomerase in human T cell differentiation, activation, aging and diseases.

Authors:  Michael Patrick; Nan-Ping Weng
Journal:  Cell Immunol       Date:  2019-09-19       Impact factor: 4.868

5.  Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.

Authors:  Carlo J Iasella; Spencer A Winters; Abigail Kois; Jaehee Cho; Stefanie J Hannan; Ritchie Koshy; Cody A Moore; Christopher R Ensor; Elizabeth A Lendermon; Matthew R Morrell; Joseph M Pilewski; Pablo G Sanchez; Daniel J Kass; Jonathan K Alder; S Mehdi Nouraie; John F McDyer
Journal:  Am J Transplant       Date:  2020-01-22       Impact factor: 8.086

6.  Cancer spectrum and outcomes in the Mendelian short telomere syndromes.

Authors:  Kristen E Schratz; Lisa Haley; Sonye K Danoff; Amanda L Blackford; Amy E DeZern; Christopher D Gocke; Amy S Duffield; Mary Armanios
Journal:  Blood       Date:  2020-05-28       Impact factor: 22.113

Review 7.  Extrahematopoietic manifestations of the short telomere syndromes.

Authors:  Kristen E Schratz
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

Review 8.  Hallmarks of T cell aging.

Authors:  Maria Mittelbrunn; Guido Kroemer
Journal:  Nat Immunol       Date:  2021-05-13       Impact factor: 25.606

Review 9.  Cancer and myeloid clonal evolution in the short telomere syndromes.

Authors:  Kristen E Schratz; Mary Armanios
Journal:  Curr Opin Genet Dev       Date:  2020-04-07       Impact factor: 5.578

Review 10.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.